Seattle, Oct. 17, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global magnetic resonance imaging (MRI) systems market is estimated to be valued at US$ 5,464.3 million in 2022 and is expected to exhibit a CAGR of 3.7 % during the forecast period (2022-2030).
Key Trends and Analysis of the global magnetic resonance imaging (MRI) systems market:
Key players involved in market are launching new products to extend their product portfolios and strengthen their market position. For instance, in November 2021, Royal Philips, a Dutch conglomerate corporation, launched new 1.5-tesla and 3-tesla MRI scanners and software-based workflow enhancements that are designed to enable radiology facilities to operate more efficiently. MR 5300 is a 1.5-tesla scanner that extends to a new scanner the BlueSeal helium-free operation concept. The technology seals helium directly into the magnet, such that BlueSeal scanners do not require helium refills or quench pipes. MR 7700, is a 3-tesla magnet that's designed to be suitable for both clinical and research purposes.
Increase in number of collaborations by market players is also expected to boost the market growth. For instance, in March 2021, Royal Philips, a Dutch conglomerate corporation collaborated with Disney, an U.S.-based mass media and entertainment conglomerate to improve the healthcare experience of children. The aim of the collaboration is to help reduce fear and anxiety to improve children’s patient experience during MRI process. Philips MRI's ambient experience will display six pieces of original, stylized Disney animation - produced specifically by Disney animators for use in hospitals with clinical advice from Philips. Characters such as Mickey Mouse, Ariel, Marvel's Avengers, Star Wars' Yoda, and others appear in the Disney animation for the first time in a diagnostic setting.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/443
Key Market Takeaways:
Global magnetic resonance imaging (MRI) systems market is expected to exhibit a CAGR of 3.7% during the forecast period due to launch of software to support radiologists in MRI-guided procedures is expected to offer lucrative growth opportunities for players in the global magnetic resonance imaging (MRI) market. For instance, in November 2019, Qlarity Imaging, a developer of computer-aided breast cancer diagnostic system, announced the launch of a complementary software to support radiologists in MRI-guided procedures.
Among region,North America held a dominant position in the global magnetic resonance imaging (MRI) systems market, owing to increasing product launches from major manufacturers in the region. For instance, in November 2021, GE Healthcare, a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals, launched a new 3-tesla scanner called Signa Hero. The scanner has several design innovations to improve radiology operations, including an ultra-wide bore (bore is the cylindrical magnet at the center of a magnetic resonance imaging (MRI) scanner) and removable table, and all patients can be photographed feet-first to alleviate claustrophobia. The launch of the system is expected to enhance GE Healthcare’s market position.
Competitive Landscape:
Key players operating in the global magnetic resonance imaging (MRI) systems market include Seimens AG, Koninklijke Philips N.V., Medtronic plc, Aurora Imaging Technologies Inc., General Electric Company, Hitachi Ltd., Esaote SpA, The InterMed Group, and Canon Medical Systems Corporation
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/443
Market Segmentation:
- Global magnetic resonance imaging (MRI) Systems Market, By Type:
- Open
- Closed
- Global magnetic resonance imaging (MRI) Systems Market, By Field Strength:
- High Field
- Mid Field
- Low Field
- Global magnetic resonance imaging (MRI) Systems Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- By Region/Country
- North America
Related Market Intelligence Reports:
Small Animal Imaging Market, by Product Type (Optical Imaging Systems {Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems, and X-Ray/Optical Imaging Systems}, Nuclear Imaging Systems {Micro-PET (Positron Emission Tomography) Systems, Micro-SPECT (Single-Photon Emission Computed Tomography) Systems, and Trimodality (SPECT/PET/CT) Systems}, MRI (Magnetic Resonance Imaging) Systems, Ultrasound Systems, CT (Computed Tomography) Systems, and Others {Photoacoustic Imaging Systems and Magnetic Particle Imaging (MPI) Systems, among others}), by Application (Monitoring Drug Treatment Response, Bio-distribution Studies, Cancer Cell Detection, Biomarkers, and Others {Longitudinal Studies and Epigenetics, among others}), by End User (Biotechnology and Pharmaceutical Companies, Academic/ Research Institutes, and Others {Contract Research Organizations, Laboratories, among others}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030
Live Cell Imaging Market, By Product (Equipment, Consumables, and Software and Services), By Application (Cell Biology, Developmental Biology, Stem Cell Biology, Drug Discovery, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
